Akèy › Maladi poumon entèstisyèl › Arizona › Phoenix
Etid klinik pou Maladi poumon entèstisyèl nan Phoenix, AZ
9 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
- USA027, Phoenix
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 2
- Arizona Heart Rhythm Center, Phoenix
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Ap rekriteFaz 2
- Phoenix, Phoenix
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Ap rekrite
- Banner University Medical Center, Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Ap rekriteFaz 3
- Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
- Banner Health - University Medical Center Phoenix, Phoenix
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Ap rekriteFaz 2
- Arizona Pulmonary Specialists, Phoenix
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Ap rekriteFaz 3
- Banner University Medical Center Phoenix Lung Institute, Phoenix
- Norton Thoracic Institute, Phoenix
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Ap rekriteEtid obsèvasyon
- Arizona Pulmonary Specialists, Phoenix
Etid Maladi poumon entèstisyèl nan lòt vil
- New York City, NY18 etid
- Philadelphia, PA16 etid
- Los Angeles, CA14 etid
- Kansas City, KS13 etid
- Durham, NC13 etid
- Charleston, SC13 etid
- Chicago, IL12 etid
- Houston, TX12 etid
- Ann Arbor, MI11 etid
- Aurora, CO11 etid
- Salt Lake City, UT9 etid
- Boston, MA9 etid
Lòt etid nan Phoenix
- Kansè nan tete25 etid
- Kansè kolorektal25 etid
- Obèsite22 etid
- Kansè Poumon ki pa ti selil20 etid
- Kansè Metastatik20 etid
- Ensifizyans kadyak18 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Myelom Miltip16 etid
- Kansè pankreyas16 etid
- Maladi kadyovaskilè16 etid
- Maladi Alzheimer15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.